Cargando…

Correlation of gyr Mutations with the Minimum Inhibitory Concentrations of Fluoroquinolones among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh

Fluoroquinolone (FQ) compounds—moxifloxacin (MOX), levofloxacin (LEV), and ofloxacin (OFL)—are used to treat multidrug-resistant tuberculosis (MDR-TB) globally. In this study, we investigated the correlation of gyr mutations among Mtb isolates with the MICs of MOX, LEV, and OFL in Bangladesh. A tota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uddin, Mohammad Khaja Mafij, Ather, Md. Fahim, Nasrin, Rumana, Rahman, Tanjina, Islam, A. S. M. Iftekhairul, Rahman, S. M. Mazidur, Ahmed, Shahriar, Banu, Sayera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623510/ https://www.ncbi.nlm.nih.gov/pubmed/34832578 http://dx.doi.org/10.3390/pathogens10111422

Ejemplares similares

Performance of WHO-Endorsed Rapid Tests for Detection of Susceptibility to First-Line Drugs in Patients with Pulmonary Tuberculosis in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2022)

Molecular Epidemiology and Genetic Diversity of Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2022)

Diagnostic Performance of Different Laboratory Methods for the Detection of Extrapulmonary Tuberculosis
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2023)

Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh
por: Rahman, S. M. Mazidur, et al.
Publicado: (2021)

Distribution and Frequency of rpoB Mutations Detected by Xpert MTB/RIF Assay Among Beijing and Non-Beijing Rifampicin Resistant Mycobacterium tuberculosis Isolates in Bangladesh
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2020)

Diagnostic Yield of Xpert MTB/RIF Assay Using Bronchoalveolar Lavage Fluid in Detecting Mycobacterium tuberculosis among the Sputum-Scarce Suspected Pulmonary TB Patients
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2022)

Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh
por: Rahman, Arfatur, et al.
Publicado: (2017)

Multidrug-Resistant Tuberculosis in Admitted Patients at a Tertiary Referral Hospital of Bangladesh
por: Banu, Sayera, et al.
Publicado: (2012)

Epidemiology of Tuberculosis in an Urban Slum of Dhaka City, Bangladesh
por: Banu, Sayera, et al.
Publicado: (2013)

Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice
por: Heysell, Scott K., et al.
Publicado: (2015)

Effect of Active Case Finding on Prevalence and Transmission of Pulmonary Tuberculosis in Dhaka Central Jail, Bangladesh
por: Banu, Sayera, et al.
Publicado: (2015)

Xpert Ultra Assay on Stool to Diagnose Pulmonary Tuberculosis in Children
por: Kabir, Senjuti, et al.
Publicado: (2020)

Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2021)

Comparison of direct versus concentrated smear microscopy in detection of pulmonary tuberculosis
por: Uddin, Mohammad Khaja Mafij, et al.
Publicado: (2013)

Occurrence of tuberculosis among people exposed to cattle in Bangladesh
por: Sarkar, Shamim, et al.
Publicado: (2023)

Yield of Two Consecutive Sputum Specimens for the Effective Diagnosis of Pulmonary Tuberculosis
por: Islam, Mohammad R., et al.
Publicado: (2013)

Comparison of Xpert MTB/RIF Assay and GenoType MTBDRplus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis
por: Rahman, Arfatur, et al.
Publicado: (2016)

Social Enterprise Model (SEM) for private sector tuberculosis screening and care in Bangladesh
por: Banu, Sayera, et al.
Publicado: (2020)

New Insights into Fluoroquinolone Resistance in Mycobacterium tuberculosis: Functional Genetic Analysis of gyrA and gyrB Mutations
por: Malik, Seidu, et al.
Publicado: (2012)

Alterations of gyrA, gyrB, and parC and Activity of Efflux Pump in Fluoroquinolone-resistant Acinetobacter baumannii
por: Park, Sunok, et al.
Publicado: (2011)

Evaluation of Xpert MTB/RIF assay for detection of Mycobacterium tuberculosis in stool samples of adults with pulmonary tuberculosis
por: Rahman, S. M. Mazidur, et al.
Publicado: (2018)

Fluoroquinolone Resistance Linked to GyrA, GyrB, and ParC Mutations in Salmonella enterica Typhimurium Isolates in Humans
por: Casin, Isabelle, et al.
Publicado: (2003)

gyrA Mutations in Fluoroquinolone-resistant Clostridium difficile PCR-027
por: Drudy, Denise, et al.
Publicado: (2007)

Prevalence and incidence of tuberculosis infection among healthcare workers in chest diseases hospitals, Bangladesh: Putting infection control into context
por: Islam, Md. Saiful, et al.
Publicado: (2023)

Pulmonary Tuberculosis and Drug Resistance in Dhaka Central Jail, the Largest Prison in Bangladesh
por: Banu, Sayera, et al.
Publicado: (2010)

Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients
por: Kabir, Saba, et al.
Publicado: (2020)

Performance of TaqMan array card to detect TB drug resistance on direct specimens
por: Banu, Sayera, et al.
Publicado: (2017)

First report of molecular detection of fluoroquinolone resistance-associated gyrA mutations in multidrug-resistant clinical Mycobacterium tuberculosis isolates in Kuwait
por: Al-Mutairi, Noura M, et al.
Publicado: (2011)

Frequency and Geographic Distribution of gyrA and gyrB Mutations Associated with Fluoroquinolone Resistance in Clinical Mycobacterium Tuberculosis Isolates: A Systematic Review
por: Avalos, Elisea, et al.
Publicado: (2015)

1495 Resistance of Fluoroquinolone in Orientia tsutsugamushi Due to gyrA Mutation in Scrub typhus
por: CHO, Soo Kyung, et al.
Publicado: (2014)

In-Depth Immunophenotyping With Mass Cytometry During TB Treatment Reveals New T-Cell Subsets Associated With Culture Conversion
por: Chedid, Carole, et al.
Publicado: (2022)

Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta
por: Nathania, Ignes, et al.
Publicado: (2022)

A Fluoroquinolone Resistance Associated Mutation in gyrA Affects DNA Supercoiling in Campylobacter jejuni
por: Han, Jing, et al.
Publicado: (2012)

A novel gyrB gene mutation in fluoroquinolone resistant clinical isolates of Mycobacterium tuberculosis
por: Singh, Pooja, et al.
Publicado: (2014)

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis
por: Li, Jing, et al.
Publicado: (2014)

gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae isolates from Kenya
por: Kivata, Mary Wandia, et al.
Publicado: (2019)

Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis
por: Anand, RS, et al.
Publicado: (2011)

Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance
por: Divya, M.P., et al.
Publicado: (2015)

The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran
por: Nouri, Roghayeh, et al.
Publicado: (2016)

Protecting frontline healthcare workers should be the top priority in low-resource health systems: Bangladesh and COVID-19
por: Hassan, Md. Zakiul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c8971dsamrm7tcfcdkres6cdka